Detention and the Evolving Threat of Tuberculosis: Evidence,Ethics,and Law

Kahn C. , “Man with Drug-Resistant TB Locked Up,” USA Today, April 12, 2007.

Altman L. , “TB Patient Is Isolated After Taking Two Flights,” New York Times, May 30, 2007.

World Health Organization, Tuberculosis Facts, 2007.

XDR-TB is defined as resistance to rifampicin and isoniazid, in addition to any fluoroquinolone, and to at least one of the three following injectable drugs used in anti-TB treatment: Capreomycin, kanamycin, and amikacin. World Health Organization, “Extensively Drug-Resistant Tuberculosis (XDR-TB): Recommendations for Prevention and Control,” The Weekly Epidemiological Record 81, no. 45 (2006): 430–32.

MDR-TB is defined as resistance to rifampicin and isoniazid with or without drug resistance to other anti-tuberculosis drugs.

Coker R. J. , “Review: Multidrug-Resistant Tuberculosis: Public Health Challenges,” Tropical Medicine and International Health 9, no. 1 (2004): 25–40.

Centers for Disease Control, “Emergence of Mycobacterium Tuberculosis with Extensive Resistance to Second-Line Drugs - Worldwide, 2000–2004,” MMWR Morbidity and Mortality Weekly Report 55, no. 11 (2006): 301–5; Gandhi N. R. Moll A. Sturm A. W. Pawinski R. Govender T. Lalloo U. Zeller K. Andrews J. Friedland G. , “Extensively Drug-Resistant Tuberculosis as a Cause of Death in Patients Co-Infected with Tuberculosis and HIV in a Rural Area of South Africa,” The Lancet 368, no. 9547 (2006): 1575–80.

Id. ( Ghandi )

Singh J. A. Upshur R. Padayatchi N. , “XDR-TB in South Africa: No Time for Denial or Complacency,” PLoS Medicine 41, no. 1 (2007): e50.

World Health Organization, Report of the Meeting of the WHO Global Task Force on XDR-TB, Geneva, 2006.

Position statement by the South African Medical Research Council, Detention of Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB), South African Medical Research Council, January 30, 2007.

Coker R. J. Mounier-Jack S. Martin R. , “Public Health Law and Tuberculosis Control in Europe,” Public Health 121, no. 4 (2007): 266–73.

Coker R. J. , “The Law, Human Rights, and the Detention of Individuals with Tuberculosis in England and Wales,” Journal of Public Health Medicine 22, no. 3 (2000): 263–67.

Coker R. , “Communicable Disease Control and Contemporary Themes in Public Health Law,” Public Health 120, Supplement (2006): 23–8, at discussion 28–9.

Martin R. , “The Exercise of Public Health Powers in Cases of Infectious Disease: Human Rights Implications,” Medical Law Review 14, no. 1 (2006): 132–43.

Coker R. , “Civil Liberties and Public Good: Detention of Tuberculous Patients and the Public Health Act 1984,” Medical History 45, no. 3 (2001): 341–58.

See Singh , supra note 9.

Coker R. J. , From Chaos to Coercion: Detention and the Control of Tuberculosis (New York: St. Martin's Press, 2000); Gostin L. O. , “Controlling the Resurgent Tuberculosis Epidemic: A 50-State Survey of TB Statutes and Proposals for Reform,” JAMA 269, no. 2 (1993): 255–61; and Gostin L. O. , Public Health Powers: The Imminence of Radical Change, paper presented at the conference proceedings, New York City, December 4–5, 1992, at 268–90.

See Singh , supra note 9.

United Nations, Economic and Social Council, Siracusa Principles on the Limitation and Derogation Provisions in the International Covenant on Civil and Political Rights , 1985; Gostin L. , Public Health Law: Power, Duty, Restraint (Berkeley/Los Angeles: University of California Press, 2000).

Coker R. J. , “Public Health Impact of Detention of Individuals with Tuberculosis: Systematic Literature Review,” Public Health 117, no. 4 (2003): 281–87.

Coker R. J. , “The Law, Human Rights, and the Detention of Individuals with Tuberculosis in England and Wales,” Journal of Public Health Medicine 22, no. 3 (2000): 263–67; see Gostin , supra note 22; Pinet G. , Good Practice in Legislation and Regulations for TB control: An Indicator of Political Will, World Health Organization, Geneva, May 2001.

Coker R. , “Just Coercion? Detention of Nonadherent Tuberculosis Patients,” Annals of the New York Academy of Sciences 953 (2001): 216–23; Coker R. , “Tuberculosis, Non-Compliance and Detention for the Public Health,” Journal of Medical Ethics 26, no. 3 (2000): 157–9.

Sepkowitz K. A. , “How Contagious Is Tuberculosis?” Clinical Infectious Diseases 23, no. 5 (1996): 954–62; Behr M. A. Warren S. A. Salamon H. Hopewell P. C. de Leon A. P. Daley C. L. Small P. M. , “Transmission of Mycobacterium Tuberculosis from Patients Smear-Negative for Acid-Fast Bacilli,” The Lancet 353, no. 9151 (1999): 444–49.

See Coker , supra note 20; Coker , supra note 23.

Heald C. , “What Future for Expert Witnesses?” BBC News Web site, July 13, 2005, available at <http://news.bbc.co.uk/1/hi/uk/4637687.stm> (last visited September 11, 2007).

See Coker , supra note 16; Coker , supra note 23.

Asch S. Leake B. Anderson R. Gelberg L. “Why Do Symptomatic Patients Delay Obtaining Care for Tuberculosis?” American Journal of Respiratory and Critical Care Medicine 157 (1998): 1244–8; Asch S. Leake B. Gelberg L. , “Does Fear of Immigration Authorities Deter Tuberculosis Patients from Seeking Care,” Western Journal of Medicine 161, no. 4 (1994): 373–76; Heymann S. J. Sell R. Brewer T. F. , “The Influence of Program Acceptability on the Effectiveness of Public Health Policy: A Study of Directly Observed Therapy for Tuberculosis,” American Journal of Public Health 88, no. 33 (1998): 442–5.

Verma G. Upshur R. E. Rea E. Benatar S. R. , “Critical Reflections on Evidence, Ethics and Effectiveness in the Management of Tuberculosis: Public Health and Global Perspectives,” BMC Medical Ethics 5, no. 2 (2004): E2.

Sontag S. , Illness as Metaphor and AIDS and its Metaphors (New York: Anchor Books, 1990).

See Coker , supra note 16; Coker , supra note 20; Coker , supra note 23.

Coker R. , “Tuberculosis, Non-Compliance and Detention for the Public Health,” Journal of Medical Ethics 26, no. 3 (2000): 157–9.

Gasner M. R. Maw K. L. Feldman G. E. Fujiwara P. I. Frieden T. R. , “The Use of Legal Action in New York City to Ensure Treatment of Tuberculosis,” New England Journal of Medicine 340, no. 5 (1999): 359–66.

Roberts M. J. Reich M. R. , “Ethical Analysis in Public Health,” The Lancet 55, no. 359 (2002): 1055–9.